The Ministry of Health and Prevention (MoHAP) in the UAE has withdrawn batch number ME051 of the API Sinocort Nasal Spray, a medication that's used to treat asthma and blocked airways.
The spray is manufactured by Amman Jordan Pharmaceutical Industries.
In a statement, MoHAP said the decision was made after a review of the batch showed it had failed to conform to the approved specifications.
Pharmacists and healthcare providers have been ordered to withdraw it from sale and return the drug to the suppliers
Users are advised to dispose of the batch and report any adverse reactions.
Dr. Amin Hussein Al Amiri, Assistant Undersecretary of the Ministry of Health and Prevention’s Public Health Policy and Licenses, and Chairman of the Supreme National Committee for Pharmacovigilance, urged people to contact them by email at ph@moh.gov.ae, through the E-system on MoHAP’s website, or the smart app ‘UAE RADAR.’
NCM forecasts cloudy weather, rain in parts of UAE
Sri Lankan President thanks UAE for flood relief efforts
Dubai’s beaches, parks reopen as weather improves
Some Dubai flights cancelled due to adverse weather conditions
Dubai deploys special patrols, emergency crew to monitor traffic during rains
Dubai private schools to shorten Friday hours from January
UAE leaders congratulate Morocco on FIFA Arab Cup win
UAE ministry urges remote work for private sector in weather-hit areas
